SUPPORTING STUDY METHODS

Study Design
A summary of the study procedures and assessments is provided in Supporting Info. Table 1 .
Dosing for the on-demand treatment of hemorrhages was dependent on the severity and type of bleeding (Supporting Info. Table 2 ). The hemostatic efficacy of treatment was rated by the subject or site staff using a 4-point ordinal scale (Supporting Info. Table 3 ).
Subject compliance with treatment was monitored by regularly scheduled telephone calls, an electronic compliance tool provided to the subject and direct review of the subject's source data at the sites and evaluation against the protocol requirements. Drug accountability was evaluated at each interval study visit and at study termination by comparing the infusions recorded in the subject diary, empty vials returned by each subject to the site, and the site's dispensing record.
SUPPORTING STUDY RESULTS
Efficacy results
The mean (range) treatment period of the per-protocol (PP) analysis set was 185 days (137 to 254) for the on-demand regimen, 362 days (283 to 397) for standard prophylaxis, and 361 days (287 to 382) for PK-tailored prophylaxis. Over these periods, a total of 1351 hemorrhages VALENTINO et al.
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Page 2 of 5 occurred in 53 subjects who were treated on-demand, 77 hemorrhages in 17 of 30 subjects treated by standard prophylaxis, and 75 hemorrhages in 14 of 23 subjects treated by PK-tailored prophylaxis. No subject treated on-demand was hemorrhage-free during the 6-month treatment period, whereas 13 of 30 and 9 of 23 subjects treated with standard and PK-tailored prophylaxis, respectively (overall 41.5%) experienced no bleeding during the 12-month prophylaxis period.
ABRs for all etiologies (spontaneous and traumatic) and types of bleeding (joint and non-joint)
for standard and PK-tailored prophylaxis were similar, and reductions in ABRs compared to ondemand treatment were also similar (Supporting Info. 
